POH 0.00% 0.0¢ progress 2023-2 trust

Ann: Phosphagenics Receives Further Arbitration Process Update, page-118

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 6,900 Posts.
    lightbulb Created with Sketch. 37

    SUMMARY OF THE INVENTIONIn accordance with the objective, the present invention provides a lyophilized parental formulation consisting of antibacterial agent daptomycin as active, tocopheryl phosphate hydrolysate mixture (TPM), which acts as an antioxidant as well as solubilizer. The present composition increases the stability of the product at room temperature after reconstitution, improves the reconstitution time, thus accelerating the administration process to the patient in need of.



    Patent History


    Publication number: 20150216928
    Type: Application
    Filed: Aug 22, 2013
    Publication Date: Aug 6, 2015
    Applicant: AGILA SPECIAL TIES PRIVATE LIMITED (BANGALORE, KA)
    Inventors: Satya Srinivas Chetlapalli (Bangalore), Srirama Sarveswara Rao Mandavilli (Bangalore), Babu Justin (Bangalore), Sathyanarayan Srinivas Meda (Bangalore)
    Application Number: 14/431,170


 
watchlist Created with Sketch. Add POH (ASX) to my watchlist
(20min delay)
Last
0.0¢
Change
0.000(0.00%)
Mkt cap ! n/a
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
POH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.